PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

Where we at?, page-115

  1. 876 Posts.
    lightbulb Created with Sketch. 78
    Interesting comments from many shareholders. Timing is of essence when managing a company such as PAR. And timing is now the reason we are in the current vulnerable predicament. We would not be in this pickle if PAR accepted partnership offers which I suspect were on the table a few years back. Unfortunately greed came into play. The trick to a successful Bio is to partner up at the right time for funding purposes.This is where PAR may have failed and now we are sitting ducks. Only way out is to give some of the farm away to a funding partnee. This will put us in a position of strength. Yes I know we will be diluted, however I suspect we will be far better off in the long run. s u rely PR is getting advice ??
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.5¢
Change
-0.010(3.77%)
Mkt cap ! $89.19M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $162.7K 620.9K

Buyers (Bids)

No. Vol. Price($)
2 25008 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 34768 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.